Avantor Inc (AVTR) Shares Surge 3.1% -- What GF Score of 71 Tells Investors
Avantor Inc (AVTR) shares increased by 3.1% to $15.81, with GuruFocus estimating a fair value of $16.87, suggesting it is undervalued by 6.3%. The company holds a GF Score of 71/100, indicating an above-average rating, largely due to strong momentum and valuation despite struggles in profitability and growth. Guru and insider buying activity signals confidence in the stock's future, but its current unprofitability warrants cautious investor consideration.
Avantor stock heads toward October 28 results as estimates hold
Avantor (AVTR) stock was trading at USD 15.77 on October 5, 2026, ahead of its Q3 2026 earnings report scheduled for October 28. Analysts have a consensus "Hold" rating with an average price target of USD 12.47, significantly below the current trading price. The company's Q2 revenue beat expectations, but the market will be focusing on profitability and guidance in the upcoming report given a year-over-year decline in adjusted EBITDA.
Wall Street Zen downgrades Avantor to Hold. Avantor stock gains 1.98 percent
Wall Street Zen downgraded Avantor (AVTR) from Buy to Hold on October 3, 2026, despite the company beating Q2 2026 earnings expectations with an adjusted EPS of USD 0.21 and revenue of USD 1.69 billion. Avantor's stock gained 1.98% to EUR 13.89 on October 5, 2026. The downgrade reflects caution over limited revenue growth and declining net income, with investors now looking to the Q3 2026 earnings release on October 28, 2026, for further clarity.
Avantor stock gained 2.06 percent ahead of Q3 results
Avantor's stock gained 2.06% to USD 15.34 ahead of its Q3 2026 earnings report, scheduled for October 28. The company previously beat Q2 revenue and EPS estimates, reporting USD 1.69 billion in revenue and adjusted EPS of USD 0.21. Despite this, analysts maintain a "Hold" consensus with an average price target below the current stock price, making the upcoming report crucial for market sentiment.
AVANTOR® TO REPORT THIRD QUARTER 2026 EARNINGS ON WEDNESDAY, OCTOBER 28, 2026
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services, announced it will release its third-quarter 2026 financial results on Wednesday, October 28, 2026. The company will also host a conference call and webcast to discuss these results, providing financial details and business updates. Interested parties can access the webcast or call by dialing the provided numbers.
Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026
Avantor, Inc. (NYSE: AVTR) announced it will release its third-quarter 2026 financial results before market open on Wednesday, October 28, 2026. The company will also host a conference call on the same day at 8:00 a.m. Eastern Time. A live audio webcast and a 30-day replay will be available on Avantor's investor relations website.
Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026
Avantor® (AVTR) has announced that it will report its third-quarter 2026 earnings on Wednesday, October 28, 2026. This news item from PR Newswire provides a headline only, indicating the upcoming financial report.
Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026
Avantor, Inc. (NYSE: AVTR) announced it will release its third quarter 2026 financial results before the market opens on Wednesday, October 28, 2026. A conference call will follow on the same day at 8:00 a.m. Eastern Time. Investors can access a live audio webcast of the session and a 30-day replay on Avantor's investor relations website.
Trading Systems Reacting to (AVTR) Volatility
This article from Stock Traders Daily discusses the volatility of Avantor Inc. (NASDAQ: AVTR), analyzing its near-term strong sentiment with a neutral mid and long-term outlook. It presents AI-generated institutional trading strategies including position trading, momentum breakout, and risk hedging strategies, along with multi-timeframe signal analysis. The analysis highlights no resistance levels above the current price, suggesting compelling upside potential for AVTR.
Avantor Taps Todd Garner as CFO After Three-Month Interim
Avantor Inc. has appointed Todd Garner as its new Executive Vice President and Chief Financial Officer, concluding a three-month interim period led by Steve Eck. Garner brings over 30 years of finance and operational experience, previously serving as CFO for CONMED Corp. In his new role, he will oversee Avantor's global finance organization, focusing on growth and shareholder value for the life sciences and advanced technology company.
[Form 3] Avantor, Inc. Initial Statement of Beneficial Ownership
This article details an Initial Statement of Beneficial Ownership (Form 3) filed by Todd W. Garner, EVP and CFO of Avantor, Inc. (AVTR), with the SEC. The filing indicates that Mr. Garner beneficially owns no securities as of the event date, September 21, 2026. This form is a standard requirement for new officers or directors of publicly traded companies.
At $16.61 a share, Avantor (AVTR) grants its CFO options that begin vesting in 2027.
Avantor, Inc.'s EVP and CFO, Todd W. Garner, was granted 49,688 restricted stock units and options for 138,632 common shares on September 21, 2026. The restricted stock units will vest in two equal annual installments, while the stock options will vest in three equal annual installments, both beginning on September 21, 2027. The options have an exercise price of $16.61 per share and are set to expire on September 21, 2036.
Form 8K Avantor Inc For: 21 September By Investing.com
This article reports on an 8K filing by Avantor Inc. on September 21, 2026, as noted by Investing.com. It indicates that the company's stock, AVTR, saw a 4.20% increase. The content of the 8K filing itself is not detailed within the article.
Avantor Appoints Todd Garner as New Chief Financial Officer
Avantor has announced the appointment of Todd Garner as its new Executive Vice President and Chief Financial Officer, effective September 21, 2026. Garner, a certified public accountant with extensive experience, will oversee all global finance functions. His compensation package includes a significant base salary, bonus eligibility, and long-term equity grants, reflecting Avantor's strategic move to strengthen its financial leadership for future growth.
Avantor (AVTR) hires new CFO with seven-figure stock grants
Avantor (AVTR) has appointed Todd Garner as its new Executive Vice President and Chief Financial Officer, effective September 21, 2026. Garner's compensation package includes a $700,000 annual base salary, a target annual cash bonus of 80% of his base salary, a $150,000 signing bonus, and an initial long-term equity grant valued at $1.5 million. He will also be eligible for future annual equity grants targeted at $3 million.
Avantor Names Todd Garner CFO to Lead Global Finance Organization
Avantor, Inc. (NYSE: AVTR) has appointed Todd Garner as executive vice president and chief financial officer, effective September 21, 2026. Garner, a veteran public-company finance executive with over 30 years of experience, will lead Avantor's global finance organization, including financial planning and analysis, accounting, treasury, tax, investor relations, and internal audit. He succeeds Steve Eck, who served as interim CFO and will return to his role as senior vice president and chief accounting officer.
Avantor Appoints Todd Garner as Executive Vice President and CFO with Detailed Compensation Package
Avantor, Inc. announced the appointment of Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026. His compensation package includes an annual base salary of $700,000, a target annual bonus of 80% of his base salary, a $150,000 signing bonus, and an initial equity award valued at $1.5 million. Garner brings extensive financial leadership experience from CONMED Corporation and C.R. Bard, Inc., and will play a key role in Avantor's Executive Leadership Team.
Avantor, Inc. Appoints Todd Garner as Executive Vice President Effective September 21, 2026
Avantor, Inc. has announced the appointment of Todd Garner as Executive Vice President, effective September 21, 2026. Garner will be responsible for the company's global finance organization, including financial planning and analysis, accounting, treasury, tax, investor relations, and internal audit. He brings over 30 years of experience from various leadership roles, including a significant tenure at C. R. Bard, Inc.
Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC
Avantor, Inc. has expanded its RIM single-use bioprocessing portfolio across the Asia Pacific (APAC) region, aiming to provide local biopharma manufacturers with improved access to its products. This strategic move, part of Avantor's "Revival" strategy, strengthens its position in the rapidly growing bioprocessing market by localizing manufacturing in China and leveraging regional supply chains. The expansion is expected to enhance supply reliability, shorten lead times, and support Avantor's long-term growth in the region.
Avantor Inc stock hits 52-week high at 15.94 USD By Investing.com
Avantor Inc. (AVTR) stock reached a new 52-week high of $15.94, driven by a 100% return over the past six months and a 36% year-to-date increase. This growth is supported by positive analyst revisions and a strong Q2 2026 performance that surpassed Wall Street expectations, leading to upgraded ratings from Wolfe Research and Jefferies. Despite the positive momentum, InvestingPro analysis suggests the stock might be slightly overvalued.
Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC
Avantor has expanded the availability of its RIM single-use bioprocessing portfolio across the Asia Pacific (APAC) region, aiming to strengthen its presence in a key biopharma manufacturing market and provide local customers with tailored solutions. This expansion, part of the company's broader Revival strategy, is expected to support long-term growth in its higher-value bioprocessing business. By manufacturing locally in China, Avantor seeks to improve supply reliability, shorten lead times, and better serve biopharma customers with customized solutions.
Avantor Expands RIM Single-Use Portfolio Across APAC
Avantor is expanding the availability of its RIM single-use bioprocessing solutions across the Asia Pacific (APAC) region. This expansion aims to provide biopharmaceutical manufacturers with better access to local solutions, ensuring continuity of supply and efficient operations. The RIM portfolio, manufactured at Avantor’s facility in Changzhou, China, includes single-use consumables and hardware to support various bioprocessing applications, offering responsive supply and tailored solutions for APAC customers.
Avantor Inc stock hits 52-week high at 15.94 USD By Investing.com
Avantor Inc's stock reached a new 52-week high of $15.94, marking a 100% return over the past six months and 36% year-to-date. This surge follows a strong Q2 2026 performance that surpassed Wall Street expectations, with the company raising its full-year outlook. Despite the positive momentum, InvestingPro analysis suggests the stock might be slightly overvalued.
Avantor Inc stock hits 52-week high at 15.94 USD
Avantor Inc (AVTR) reached a new 52-week high of $15.94, driven by a 100% return over the past six months and a 36% year-to-date increase. This growth is supported by positive Q2 2026 results, surpassing Wall Street expectations, and subsequent analyst upgrades from Wolfe Research and Jefferies. Despite the positive momentum, InvestingPro analysis suggests the stock might be slightly overvalued at current levels.
Insider Stock Buying Reaches US$8.69m On Avantor
This article reports on significant insider buying at Avantor, with insiders purchasing US$8.69 million worth of shares over the last year. Despite this, the stock price has only increased by 1.6% in the past week. The article highlights that while insider buying can be a positive signal, investors should also consider the broader market context and the company's fundamentals.
Avantor Sets October 14, 2026 Departure Date for EVP Benoit Gourdier
Avantor, Inc. announced that Benoit Gourdier, Executive Vice President of Bioscience and Medtech Products, will depart the company on October 14, 2026. This date was confirmed via an updated Form 8-K/A, detailing a transition agreement finalized on August 21, 2026. Under the agreement, Gourdier will be eligible for severance benefits consistent with Avantor's Executive Severance and Change in Control Plan.
Why Is Avantor (AVTR) Up 5.4% Since Last Earnings Report?
Avantor, Inc. (AVTR) shares have increased by 5.4% since its last earnings report, outperforming the S&P 500. The company reported better-than-expected Q2 2026 earnings due to growth in its VWR Distribution & Services segment, leading to raised full-year sales and EPS guidance. Despite a decline in its Bioscience & Medtech Products segment, analyst estimates for AVTR have been trending upward, earning it a Zacks Rank #2 (Buy).
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into Avantor, Inc. (AVTR) regarding potential corporate wrongdoing by its officers and directors. The firm encourages shareholders who purchased Avantor securities before March 5, 2024, and continue to hold them, to join the investigation. Bronstein, Gewirtz & Grossman, LLC represents investors on a contingency fee basis and seeks to recover investor capital and ensure corporate accountability.
Does Avantor (AVTR) Analysts’ Upgrades Hint at Durable Fundamental Strength or Short‑Term Optimism?
Avantor (AVTR) recently received an upgrade to Rank #2 (Buy) from Zacks, accompanied by upward revisions to its full-year earnings estimates and improved analyst sentiment. Despite current margin and leverage pressures, analysts are showing increased optimism due to Avantor's strong year-to-date performance compared to the broader Medical sector. However, recent Q2 2026 results showed flat sales and a decline in net income, highlighting that the challenge for Avantor remains converting modest top-line growth into stronger earnings to sustain this positive outlook.
Does Avantor (AVTR) Analysts’ Upgrades Hint at Durable Fundamental Strength or Short‑Term Optimism?
Research firm Zacks upgraded Avantor (AVTR) to a Rank #2 (Buy) and revised its full-year earnings estimates upwards, signaling improved analyst sentiment. This optimism aligns with Avantor's stronger year-to-date performance compared to the Medical sector, suggesting perceived fundamental strength. Despite this, the company faces challenges with flat sales and declining net income in Q2 2026, highlighting the ongoing tension between positive outlooks and prevailing margin and leverage pressures.
Avantor (NYSE: AVTR) CEO keeps 737,334 shares after RSU tax withholding
Avantor's CEO, Emmanuel Ligner, had 29,803 shares of common stock withheld for tax obligations related to RSU vesting. The withholding was valued at $13.33 per share, and Ligner now directly holds 737,334 shares of Avantor common stock. This transaction was reported via a Form 4 filing and is not considered a market sale.
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avantor, Inc. (NYSE:AVTR) securities who bought shares prior to March 5, 2024, and still hold them. The investigation aims to determine if Avantor and its officers engaged in corporate wrongdoing. Investors are encouraged to contact the firm to learn more and assist with the investigation.
Zacks Research Predicts Increased Earnings for Avantor
Zacks Research has increased its FY2026 EPS forecast for Avantor to $0.80, up from $0.78, and projects further growth in FY2027 and FY2028, aligning closely with the consensus estimate. This revision follows Avantor's recent strong quarterly performance, which exceeded revenue and EPS expectations. Despite the positive earnings outlook, analyst sentiment remains cautious, with a consensus "Hold" rating for the stock.
Western Standard LLC Invests $20.89 Million in Avantor, Inc. $AVTR
Western Standard LLC has acquired a new stake in Avantor, Inc. (NYSE:AVTR) worth approximately $20.89 million, making it their fifth largest position. Despite cautious analyst sentiment with a "Hold" rating, Avantor exceeded quarterly expectations with strong EPS and revenue figures. The company's stock is currently trading at $13.97, within a 12-month range of $7.26 to $15.93.
Is Avantor (AVTR) Outperforming Other Medical Stocks This Year?
Avantor, Inc. (AVTR) has outperformed the Medical sector year-to-date, returning 16.3% compared to the sector's 3.6%. The company holds a Zacks Rank of #2 (Buy) and its full-year earnings estimate has increased by 3.1% recently. Another strong performer in the Medical Services industry is BrightSpring Health Services, Inc. (BTSG), which has returned 58.9% and has a Zacks Rank #1 (Strong Buy).
GSA Capital Partners LLP Acquires New Stake in Avantor, Inc. $AVTR
GSA Capital Partners LLP has acquired a new stake in Avantor, Inc. (NYSE:AVTR), purchasing 80,841 shares valued at approximately $800,000 during the second quarter. This move is part of a broader trend where several institutional investors are increasing their holdings in Avantor, which currently sees 95.08% institutional ownership. Despite a generally cautious "Hold" rating from Wall Street analysts with an average price target of $12.00, Avantor recently exceeded quarterly EPS and revenue estimates, reaffirming its fiscal 2026 EPS guidance.
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Shareholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Avantor, Inc. (AVTR) shareholders who purchased securities prior to March 5, 2024. The investigation concerns whether Avantor and its officers engaged in corporate wrongdoing. The firm encourages affected investors to contact them for more information, emphasizing that there is no cost to the investors unless they are successful in recovering funds.
Avantor (NYSE: AVTR) HR chief has 181 shares withheld for taxes
Avantor's EVP, Chief HR Officer, Brittany Hankamer, had 181 shares of common stock withheld on August 14, 2026, to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs). The shares were valued at $13.66 each. Following this transaction, Hankamer directly holds 248,864 shares of Avantor common stock.
Avantor, Inc. (NYSE:AVTR) Receives Average Recommendation of "Hold" from Analysts
Analysts have issued an average "Hold" recommendation for Avantor, Inc. (NYSE:AVTR), with a consensus 12-month price target of $12.00. The company recently surpassed Q2 earnings expectations, reporting $0.21 EPS on $1.69 billion revenue. Institutional investors hold a significant 95.08% stake in Avantor.
OneDigital Investment Advisors LLC Makes New Investment in Avantor, Inc. $AVTR
OneDigital Investment Advisors LLC has acquired a new stake of 142,922 shares in Avantor, Inc. (NYSE:AVTR) during the second quarter, valued at approximately $1.4 million. Institutional investors collectively own 95.08% of Avantor. The company recently reported quarterly earnings of $0.21 per share, exceeding estimates, with revenues of $1.69 billion.
Oppenheimer Asset Management Inc. Acquires Shares of 81,327 Avantor, Inc. $AVTR
Oppenheimer Asset Management Inc. has acquired 81,327 shares of Avantor, Inc. (NYSE:AVTR) valued at approximately $805,000 during the second quarter. Other institutional investors have also increased their holdings in Avantor, with institutions collectively owning 95.08% of the company's stock. Despite a consensus "Hold" rating from analysts and an average price target of $12.00, Avantor exceeded quarterly expectations with $0.21 EPS and $1.69 billion in revenue.
Diamond Hill Capital Management LLC Investment Advisor Acquires Shares of 1,046,390 Avantor, Inc. $AVTR
Diamond Hill Capital Management LLC Investment Advisor has acquired a new stake of 1,046,390 shares in Avantor, Inc. (NYSE:AVTR), valued at approximately $10.359 million, as per their recent SEC filing. Other institutional investors also made significant adjustments to their holdings in Avantor. The article details Avantor's recent price performance, earnings, and analyst ratings, noting an average "Hold" rating and a target price of $12.00 from analysts.
Handelsbanken Fonder AB Buys 81,200 Shares of Avantor, Inc. $AVTR
Handelsbanken Fonder AB increased its stake in Avantor, Inc. by 41.2% in the second quarter, purchasing 81,200 additional shares and bringing its total holdings to 278,500 shares valued at approximately $2.76 million. Institutional investors now own 95.08% of the stock. Despite a consensus "Hold" rating from analysts with an average price target of $12.00, Avantor exceeded quarterly earnings and revenue expectations and maintained its fiscal 2026 EPS guidance.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Investors to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avantor, Inc. (AVTR) securities who bought shares prior to March 5, 2024, and still hold them. The investigation focuses on possible corporate wrongdoing by Avantor officers and/or directors. The firm encourages affected investors to contact them to assist with the investigation, which is conducted on a contingency fee basis.
First Trust Advisors LP Has $230,000 Stock Position in Avantor, Inc. $AVTR
First Trust Advisors LP significantly reduced its stake in Avantor, Inc. by 98.6% in the first quarter, now holding 29,376 shares valued at $230,000. Despite this, institutional investors collectively own 95.08% of Avantor, and analysts maintain a "Hold" rating with a consensus price target of $12.00. The company recently surpassed earnings expectations, reporting $0.21 EPS on $1.69 billion revenue.
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Stockholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avantor, Inc. (NYSE:AVTR) securities. The investigation focuses on whether Avantor and its officers engaged in corporate wrongdoing, particularly for investors who purchased shares before March 5, 2024, and still hold them. The firm encourages affected stockholders to visit its website or contact its representatives to assist with the investigation, which is conducted on a contingency fee basis.
Avantor, Inc. $AVTR Shares Purchased by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. significantly increased its stake in Avantor, Inc. (NYSE:AVTR) by 425% in the second quarter, acquiring an additional 450,801 shares, bringing its total holdings to 556,871 shares valued at approximately $5.5 million. This purchase contributes to institutional investors collectively owning 95.08% of the company's stock. Despite the increased institutional interest, analysts largely maintain a "Hold" rating on Avantor with an average price target of $12.00, though the company recently surpassed quarterly earnings and revenue expectations and reaffirmed its fiscal 2026 EPS guidance.
Bank of America Corp DE Has $55.41 Million Holdings in Avantor, Inc. $AVTR
Bank of America Corp DE increased its stake in Avantor, Inc. (NYSE:AVTR) by 24.3% in the first quarter, now holding 7,067,563 shares valued at $55.41 million. Other institutional investors also adjusted their positions in Avantor, which currently has a market capitalization of $9.32 billion and recently reported earnings per share that beat analyst estimates. The company has an average analyst rating of "Hold" with a consensus target price of $12.00.
Margin Squeeze And Buybacks Might Change The Case For Investing In Avantor (AVTR)
Avantor (AVTR) reported a margin squeeze in Q2 and H1 2026, with sales increasing but net income decreasing significantly compared to the previous year. Despite the decline in profitability, the company completed a share repurchase program of 6,629,063 shares for US$74.97 million, raising questions about capital allocation priorities. The article suggests that sustained margin compression could impact the investment narrative, with some analysts already projecting lower revenue and earnings for Avantor by 2029.
Margin Squeeze And Buybacks Might Change The Case For Investing In Avantor (AVTR)
Avantor, Inc. (AVTR) reported Q2 and first-half 2026 results showing increased sales but decreased net income, indicating margin compression. Despite the earnings squeeze, the company completed a significant share repurchase program, buying back 6,629,063 shares for US$74.97 million. This capital allocation decision raises questions about management's priorities amidst profitability challenges, suggesting investors should consider how sustained margin pressure could impact the company's investment narrative and risk profile.
